← Open Payments lookup

YUKI ROSENKOETTER: Open Payments

NPI 1487744009 · LA JOLLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,313 in 96 payments from 16 companies in 2025. Trend: 2023 $1,739 · 2024 $7,745 · 2025 $3,313

Food & beverage: $2,293Speaker / faculty: $1,020
CompanyPaymentsAmount
Madrigal Pharmaceuticals4$1,095
ABBVIE INC.32$713
Gilead Sciences, Inc.9$403
Takeda Pharmaceuticals U.S.A., Inc.8$213
Janssen Biotech, Inc.9$184
Celltrion USA Inc.9$158
GENZYME CORPORATION4$126
Intercept Pharmaceuticals, Inc.4$85
AstraZeneca Pharmaceuticals LP3$81
Regeneron Healthcare Solutions, Inc.3$76

Products named: REZDIFFRA, MAVYRET, LINZESS, TREMFYA, DUPIXENT, ENTYVIO, RINVOQ, VEGZELMA.

Industry payments across CA — which companies pay providers there.